Cargando…
T cell receptor affinity and avidity defines antitumor response and autoimmunity in T cell immunotherapy
Autores principales: | Krogsgaard, Michelle, Zhong, Shi, Malecek, Karolina, Johnson, Laura A, Yu, Zhiya, Vega-Saenz de Miera, Eleazar, Darvishian, Farbod, McGary-Shipper, Katelyn, Huang, Kevin, Boyer, Joshua, Corse, Emily, Shao, Yongzhao, Rosenberg, Steven A, Restifo, Nicholas P, Osman, Iman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991230/ http://dx.doi.org/10.1186/2051-1426-1-S1-P242 |
Ejemplares similares
-
Engineering the immune response to "self" for effective cancer immunotherapy
por: Zhong, Shi, et al.
Publicado: (2014) -
Deletion of PTENP1 pseudogene in human melanoma
por: Poliseno, Laura, et al.
Publicado: (2011) -
Impact of aging on host immune response and survival in melanoma: an analysis of 3 patient cohorts
por: Weiss, Sarah A., et al.
Publicado: (2016) -
Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy
por: Moogk, Duane, et al.
Publicado: (2014) -
The Quest for the Best: How TCR Affinity, Avidity, and Functional Avidity Affect TCR-Engineered T-Cell Antitumor Responses
por: Campillo-Davo, Diana, et al.
Publicado: (2020)